Nomura Holdings’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-10,000
Closed -$1.77M 1361
2020
Q1
$1.77M Sell
10,000
-3,700
-27% -$697K 0.01% 487
2019
Q4
$2.62M Buy
13,700
+3,700
+37% +$667K 0.01% 595
2019
Q3
$1.67M Buy
+10,000
New +$1.63M 0.01% 696
2018
Q1
Sell
-24,300
Closed -$3.98M 1780
2017
Q4
$3.98M Hold
24,300
0.01% 685
2017
Q3
$4.98M Hold
24,300
0.01% 548
2017
Q2
$5.91M Buy
+24,300
New +$5.71M 0.01% 495
2017
Q1
Sell
-192,900
Closed -$40.5M 1730
2016
Q4
$40.5M Buy
192,900
+141,400
+275% +$29.3M 0.1% 120
2016
Q3
$11.9M Sell
51,500
-104,200
-67% -$25.5M 0.03% 250
2016
Q2
$35.9M Buy
155,700
+79,900
+105% +$18.4M 0.12% 93
2016
Q1
$20.4M Sell
75,800
-186,700
-71% -$53.4M 0.07% 125
2015
Q4
$82.1M Buy
+262,500
New +$78.2M 0.23% 51
2015
Q2
Sell
-36,000
Closed -$10.5M 2146
2015
Q1
$10.5M Sell
36,000
-181,600
-83% -$51.8M 0.03% 221
2014
Q4
$55.3M Buy
217,600
+10,400
+5% +$2.6M 0.15% 90
2014
Q3
$49.6M Buy
207,200
+5,900
+3% +$1.32M 0.13% 133
2014
Q2
$44.6M Buy
201,300
+199,300
+9,965% +$41.3M 0.01% 175
2014
Q1
$412K Buy
+2,000
New +$396K ﹤0.01% 1895

Other funds holding AGN

Nomura Holdings's AGN Position: Q2 2020 in Review

Nomura Holdings sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 3,016,267 shares — an estimated $534M sold.

Nomura Holdings first reported a position in AGN in Q2 2013 and held it in 25 quarters. The position peaked at $534M in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Nomura Holdings reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Nomura Holdings sold 3,016,267 Allergan plc shares in Q2 2020, an estimated $534M.
  • Nomura Holdings first reported a position in Allergan plc in Q2 2013 and held it in 25 quarters.
  • Nomura Holdings's Allergan plc position peaked at $534M in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Nomura Holdings's 13F filing for Q2 2020, filed 14 Aug 2020.